source
- Kyverna reports positive one-year CAR-T results for rare stiff person syndrome, supporting FDA filingKyverna Therapeutics announced that its CAR-T therapy for stiff person syndrome showed positive results after one year of treatment. The trial involved patients with the rare autoimmune disorder,…
- Senators question FDA nominee as agency issues rule to cut animal testingThe latest FDA briefing highlighted two key developments: a Senate hearing on the agency’s next leader and a new regulation targeting animal testing. During the confirmation hearing, senators pres…